X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1514) 1514
Publication (76) 76
Book Review (9) 9
Newsletter (8) 8
Magazine Article (5) 5
Newspaper Article (4) 4
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1438) 1438
goserelin - therapeutic use (757) 757
female (747) 747
male (732) 732
goserelin (645) 645
middle aged (604) 604
antineoplastic agents, hormonal - therapeutic use (554) 554
prostatic neoplasms - drug therapy (547) 547
adult (482) 482
aged (463) 463
oncology (429) 429
breast neoplasms - drug therapy (314) 314
index medicus (296) 296
antineoplastic combined chemotherapy protocols - therapeutic use (283) 283
buserelin - analogs & derivatives (276) 276
buserelin - therapeutic use (275) 275
treatment outcome (270) 270
goserelin - administration & dosage (267) 267
prostate cancer (257) 257
prostatic neoplasms - pathology (247) 247
androgen antagonists - therapeutic use (236) 236
aged, 80 and over (217) 217
cancer (195) 195
chemotherapy, adjuvant (195) 195
urology & nephrology (182) 182
gonadotropin-releasing hormone - agonists (180) 180
premenopause (180) 180
obstetrics & gynecology (173) 173
carcinoma (172) 172
combined modality therapy (172) 172
breast cancer (168) 168
follow-up studies (163) 163
care and treatment (158) 158
goserelin - adverse effects (156) 156
prostatic neoplasms - blood (151) 151
tamoxifen (150) 150
therapy (148) 148
prostate-specific antigen - blood (147) 147
prostatic neoplasms - radiotherapy (144) 144
orchiectomy (143) 143
prospective studies (143) 143
leuprolide - therapeutic use (140) 140
testosterone - blood (139) 139
antineoplastic agents, hormonal - administration & dosage (134) 134
time factors (133) 133
gonadotropin-releasing hormone - analogs & derivatives (130) 130
neoplasm staging (130) 130
tamoxifen - therapeutic use (130) 130
disease-free survival (128) 128
prostatic neoplasms - therapy (128) 128
radiotherapy (127) 127
prostatic neoplasms - mortality (126) 126
women (121) 121
chemotherapy (119) 119
flutamide - therapeutic use (119) 119
endometriosis - drug therapy (112) 112
prostatic neoplasms - surgery (112) 112
adenocarcinoma - drug therapy (109) 109
delayed-action preparations (105) 105
prognosis (104) 104
breast neoplasms - pathology (101) 101
antineoplastic agents, hormonal - adverse effects (99) 99
survival rate (97) 97
buserelin - administration & dosage (94) 94
menopause (92) 92
drug therapy, combination (91) 91
luteinizing hormone - blood (91) 91
retrospective studies (90) 90
trial (87) 87
radical prostatectomy (86) 86
endocrinology & metabolism (85) 85
gonadotropin-releasing hormone - therapeutic use (83) 83
survival analysis (83) 83
estradiol - blood (82) 82
randomized controlled trials as topic (81) 81
follicle stimulating hormone - blood (79) 79
anilides - therapeutic use (78) 78
flutamide - administration & dosage (78) 78
uterine neoplasms - drug therapy (76) 76
leiomyoma - drug therapy (75) 75
survival (75) 75
tamoxifen - administration & dosage (74) 74
radiation-therapy (73) 73
neoplasms, hormone-dependent - drug therapy (72) 72
antineoplastic agents - therapeutic use (71) 71
cyclophosphamide (71) 71
drug administration schedule (71) 71
medicine, general & internal (71) 71
research (71) 71
testosterone (71) 71
estrogen (69) 69
health aspects (69) 69
hormones (69) 69
endocrine therapy (67) 67
endometriosis (65) 65
flutamide (64) 64
nitriles - therapeutic use (64) 64
ovariectomy (63) 63
antineoplastic combined chemotherapy protocols - adverse effects (61) 61
postmenopausal women (61) 61
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1384) 1384
Japanese (38) 38
German (20) 20
Italian (20) 20
French (19) 19
Bulgarian (14) 14
Chinese (12) 12
Russian (8) 8
Spanish (8) 8
Polish (4) 4
Czech (2) 2
Serbian (2) 2
Dutch (1) 1
Hebrew (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 7, pp. 679 - 691
This large trial tested the effect of adding zoledronic acid to adjuvant endocrine treatment (goserelin plus tamoxifen or anastrozole) in premenopausal women... 
RECEIVING ADJUVANT LETROZOLE | MULTIPLE-MYELOMA | OVARIAN ABLATION | BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS | MEDICINE, GENERAL & INTERNAL | BONE LOSS | SOLID TUMORS | TAMOXIFEN | DELTA-T-CELLS | POSTMENOPAUSAL WOMEN | AUSTRIAN BREAST | Breast Neoplasms - surgery | Triazoles - adverse effects | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Chemotherapy, Adjuvant | Imidazoles - therapeutic use | Drug Therapy, Combination | Goserelin - therapeutic use | Aromatase Inhibitors - therapeutic use | Diphosphonates - adverse effects | Triazoles - therapeutic use | Bone Density Conservation Agents - adverse effects | Premenopause | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Estrogen Antagonists - therapeutic use | Tamoxifen - therapeutic use | Estrogen Antagonists - adverse effects | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Zoledronic acid | Care and treatment | Usage | Breast cancer | Health aspects | Function tests (Medicine) | Chemotherapy | Acids | Womens health | Menopause | Colorectal cancer | Cytotoxicity | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 7, pp. 631 - 641
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 07/2011, Volume 306, Issue 3, pp. 269 - 276
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 6, Issue 6, p. CD009266
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 10/2017, Volume 117, Issue 8, pp. 1233 - 1240
Background: As androgen deprivation therapy (ADT) is increasingly being used in men with localised prostate cancer, our goal was to examine the association... 
androgen deprivation therapy | MORTALITY | cardiovascular disease | METAANALYSIS | DEATH | SUPPRESSION | TRIAL | prostate cancer | ONCOLOGY | MEN | TESTOSTERONE DEFICIENCY | RADIOTHERAPY | CORONARY-HEART-DISEASE | DURATION | Multivariate Analysis | Anilides - therapeutic use | Prospective Studies | Humans | Middle Aged | Male | Neoplasm Grading | Antineoplastic Agents, Hormonal - therapeutic use | Cardiovascular Diseases - epidemiology | Flutamide - therapeutic use | Goserelin - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Heart Failure - epidemiology | Prostatic Neoplasms - drug therapy | Arrhythmias, Cardiac - epidemiology | Prostatic Neoplasms - pathology | California - epidemiology | Risk Factors | Proportional Hazards Models | Imidazolidines - therapeutic use | Prostatic Neoplasms - epidemiology | Tosyl Compounds - therapeutic use | Leuprolide - therapeutic use | Androgen Antagonists - therapeutic use | Aged | Cohort Studies | Nitriles - therapeutic use | Heart failure | Heart | Drugs | Therapy | Conduction | Deprivation | Arrhythmia | Risk groups | Health risks | Cardiovascular disease | Risk analysis | Minority & ethnic groups | Patients | Risk factors | Surveillance | Failure analysis | Men | Cardiovascular diseases | Health risk assessment | Prostate cancer | Heart diseases | Prostate | Cancer | Tumors | Epidemiology
Journal Article
The Oncologist, ISSN 1083-7159, 09/2017, Volume 22, Issue 9, pp. 1028 - 1038
Journal Article